Preview

Nephrology (Saint-Petersburg)

Advanced search
Open Access Open Access  Restricted Access Subscription Access

Nephrogenic diabetes insipidus – rare clinical cases

https://doi.org/10.36485/1561-6274-2025-29-3-108-113

EDN: NDFILB

Abstract

Nephrogenic diabetes insipidus is an orphan disease characterized by the kidneys' inability to concentrate urine due to insensitivity of the distal nephron to antidiuretic hormone. Primary (hereditary) nephrogenic diabetes insipidus is often diagnosed in childhood and is associated with mutations in the AVPR2 and AQP2 genes. Secondary nephrogenic diabetes insipidus, in most cases, is identified in adult patients against the backdrop of diseases that impair renal concentrating function, therapy with agents that suppress AQP2 expression, and metabolic disorders, such as hypokalemia and hyperkalemia. In congenital abnormalities of the urinary system, secondary nephrogenic diabetes insipidus may also develop in early childhood due to impaired urodynamics. The clinical presentation of the disease is characterized by a polyuria-polydipsia syndrome, which significantly depends on the degree of dehydration and the timely compensation of renal fluid losses through adequate water intake. In severe cases, serious complications may arise, including hypernatremic dehydration and delays in physical and psychomotor development in young children. Given the diversity of potential clinical manifestations, the diagnosis of nephrogenic diabetes insipidus poses a challenging task in medical practice. This article describes two clinical cases of patients with genetically determined and secondary nephrogenic diabetes insipidus. Both men exhibit clinically similar symptoms from birth. However, given the differing etiology of the conditions, the treatment approaches vary. Timely detection of the condition and an appropriate therapeutic strategy can significantly enhance the quality of life for patients and prevent serious complications.

About the Authors

M. S. Berlovich
Endocrinology Research Centre
Russian Federation

Clinical resident Mariia S. Berlovich MD, Department of Neuroendocrinology

117292, Moscow, Dm. Ulyanov St., build 11

Phone: (495)6682079 (ext.7602)



Yu. A. Aleynikova
Endocrinology Research Centre
Russian Federation

Clinical resident Yulia A. Aleynikova MD, Department of Neuroendocrinology

117292, Moscow, Dm. Ulyanov St., build 11

Phone: (495)6682079 (ext.7602)



L. G. Ebanoidze
Endocrinology Research Centre
Russian Federation

Postgraduate student Laura G. Ebanoidze, Department of Neuroendocrinology

117292, Moscow, Dm. Ulyanov St., build 11

Phone: (495)6682079 (ext.7602)



E. A. Pigarova
Endocrinology Research Centre
Russian Federation

Leading researcher Ekaterina A. Pigarova, MD, PhD, DMedSci, doctor of the highest qualifi cation category, Department of Neuroendocrinology

117292, Moscow, Dm. Ulyanov St., build 11

Phone: (495)6682079 (доб.3333)



L. K. Dzeranova
Endocrinology Research Centre
Russian Federation

Prof. Larisa K. Dzeranova, MD, PhD, DMedSci, doctor of the highest qualifi cation category, Department of Endocrinology of Higher and Additional Professional Education, Chief Researcher of the Department of Neuroendocrinology

117292, Moscow, Dm. Ulyanov St., build 11

Phone: (495)6682079 (доб.5430)



References

1. Fenske W, Allolio B. Clinical review: Current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab 2012;97(10):3426–3437. doi:10.1210/jc.2012-1981

2. Arima H, Cheetham T, Christ-Crain M et al. Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus. J Clin Endocrinol Metab 2022;108(1):1–3. doi:10.1210/clinem/dgac547

3. Prentice M. Time for change: Renaming Diabetes Insipidus to improve patient safety. Clin Endocrinol (Oxf) 2018;88(5):625–626. doi:10.1111/cen.13578

4. Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 2015;11(10):576–588. doi:10.1038/nrneph.2015.89

5. Christ-Crain M, Gaisl O. Diabetes insipidus. Presse Med 2021;50(4):104093. doi:10.1016/j.lpm.2021.104093

6. Dzeranova LK, Pigarova EA. Nesakharnyy diabet. In: Endocrinology: National guidelines. Ed. by Dedov I, Mel’nichenko G. GEOTAR-Media, M., 2008: 673–677 (In Russ.)

7. Bockenhauer D, van't Hoff W, Dattani M et al. Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases. Nephron Physiol 2010;116(4):p23–p29. doi: 10.1159/000320117

8. Trepiccione F, Christensen BM. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J Nephrol 2010;23 Suppl 16:S43–S48

9. Stavroulopoulos A, Nakopoulou L, Xydakis AM, Aresti V, Nikolakopoulou A, Klouvas G. Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexed. Ren Fail 2010;32(8):1000–1004. doi:10.3109/0886022X.2010.501930

10. Пигарова ЕА. Несахарный диабет: эпидемиология, клиническая симптоматика, подходы к лечению. Доктор.Ру. 2009. №6-2. URL: https://cyberleninka.ru/article/n/nesaharnyy-diabet-epidemiologiya-klinicheskaya-simptomatika-podhody-k-lecheniyu

11. Saborio P, Tipton GA, Chan JC. Diabetes insipidus. Pediatr Rev 2000;21(4):122–129. doi:10.1542/pir.21-4-122

12. Hong EG, Suh Y, Chung YS, et al. A case of nephrogenic diabetes insipidus caused by obstructive uropathy due to prostate cancer. Yonsei Med J 2000;41(1):150–154. doi: 10.3349/ymj.2000.41.1.150

13. Qizalbash, Mohammad Ali Raza, Rida Zahra et al. “Nephrogenic Diabetes Insipidus Due to Urinary Tract Obstruction: A Systematic Review”, 2017: Internal Medicine And Medical Investigation Journal 2017: 2(4): 113–131. doi: 10.24200/imminv.v2i4.110

14. Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 20e. McGraw-Hill Education; 2018. Accessed February 28, 2025. https://accessmedicine.mhmedical.com/content.aspx?bookid=2129&sectionid=159213747

15. Park YJ, Baik HW, Cheong HI, Kang JH. Congenital nephrogenic diabetes insipidus with a novel mutation in the aquaporin 2 gene. Biomed Rep 2014;2(4):596–598. doi:10.3892/br.2014.283

16. Joshi S, Brandstrom P, Gregersen N, Rittig S, Christensen JH. Novel de novo AVPR2 Variant in a Patient with Congenital Nephrogenic Diabetes Insipidus. Case Rep Nephrol Dial 2017;7(3):130–137. Published 2017 Sep 27. doi: 10.1159/000480009

17. D'Alessandri-Silva C, Carpenter M, Ayoob R et al. Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study. Front Pediatr 2020;7:550. Published 2020 Jan 21. doi:10.3389/fped.2019.00550

18. Ma L, Wu D, Wang X, Yang Y. A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr108Met Variant of Aquaporin 2. Front Pediatr 2020;8:15. Published 2020 Jan 30. doi:10.3389/fped.2020.00015

19. Sinke AP, Kortenoeven ML, de Groot T et al. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter. Am J Physiol Renal Physiol 2014;306(5):F525–F533. doi:10.1152/ajprenal.00617.2013


Review

For citations:


Berlovich M.S., Aleynikova Yu.A., Ebanoidze L.G., Pigarova E.A., Dzeranova L.K. Nephrogenic diabetes insipidus – rare clinical cases. Nephrology (Saint-Petersburg). 2025;29(3):108-113. (In Russ.) https://doi.org/10.36485/1561-6274-2025-29-3-108-113. EDN: NDFILB

Views: 42


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)